The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Revisiting IL-2: Biology and therapeutic prospects
Abstract
Deeper insights into the biology of interleukin-2 and its receptors are leading to therapeutic strategies for selective T reg stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Genetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Self-citationA function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
A large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
de Lange, K. M., Moutsianas, L., Lee, J. C., Lamb, C. A., Luo, Y., Kennedy, N. A., Jostins, L., Rice, D. L., Gutierrez-Achury, J., Ji, S.-G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3760 · Cited by 1,445
Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D'Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,320
IL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
BIRAC Consortium, Stahl, E. A., YEAR Consortium, Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.582 · Cited by 1,253
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Structure and expression of a cloned cDNA for human interleukin-2
Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., & Hamuro, J. (1983) · Nature · doi:10.1038/302305a0 · Cited by 1,182
the Wellcome Trust Case Control Consortium, Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. R., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,155
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Multiple common variants for celiac disease influencing immune gene expression
Dubois, P. C. A., Trynka, G., Franke, L., Hunt, K. A., Romanos, J., Curtotti, A., Zhernakova, A., Heap, G. A. R., Ádány, R., Aromaa, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.543 · Cited by 1,024
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
An essential role for the IL-2 receptor in Treg cell function
Chinen, T., Kannan, A. K., Levine, A. G., Fan, X., Klein, U., Zheng, Y., Gasteiger, G., Feng, Y., Fontenot, J. D., & Rudensky, A. Y. (2016) · Nature Immunology · doi:10.1038/ni.3540 · Cited by 888
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes
Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D., & Sprent, J. (2006) · Science · doi:10.1126/science.1122927 · Cited by 870
Reprogramming human T cell function and specificity with non-viral genome targeting
Roth, T. L., Puig-Saus, C., Yu, R., Shifrut, E., Carnevale, J., Li, P. J., Hiatt, J., Saco, J., Krystofinski, P., Li, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0326-5 · Cited by 839
Self-citationGenome-wide association study in alopecia areata implicates both innate and adaptive immunity
Petukhova, L., Duvic, M., Hordinsky, M., Norris, D., Price, V., Shimomura, Y., Kim, H., Singh, P., Lee, A., Chen, W. V., et al. (2010) · Nature · doi:10.1038/nature09114 · Cited by 830
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729
Self-citationType 1 Diabetes Genetics Consortium, Onengut-Gumuscu, S., Chen, W.-M., Burren, O., Cooper, N. J., Quinlan, A. R., Mychaleckyj, J. C., Farber, E., Bonnie, J. K., Szpak, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3245 · Cited by 680
van Heel, D. A., Franke, L., Hunt, K. A., Gwilliam, R., Zhernakova, A., Inouye, M., Wapenaar, M. C., Barnardo, M. C. N. M., Bethel, G., Holmes, G. K. T., et al. (2007) · Nature Genetics · doi:10.1038/ng2058 · Cited by 669
Interaction of IL-2Rβ and γ c Chains with Jak1 and Jak3: Implications for XSCID and XCID
Russell, S. M., Johnston, J. A., Noguchi, M., Kawamura, M., Bacon, C. M., Friedmann, M., Berg, M., McVicar, D. W., Witthuhn, B. A., Silvennoinen, O., et al. (1994) · Science · doi:10.1126/science.7973658 · Cited by 655
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
Klatzmann, D., & Abbas, A. K. (2015) · Nature Reviews Immunology · doi:10.1038/nri3823 · Cited by 636
Self-citationthe EArly Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium (2015) · Nature Genetics · doi:10.1038/ng.3424 · Cited by 621
Fine-mapping inflammatory bowel disease loci to single-variant resolution
International Inflammatory Bowel Disease Genetics Consortium, Huang, H., Fang, M., Jostins, L., Umićević Mirkov, M., Boucher, G., Anderson, C. A., Andersen, V., Cleynen, I., Cortes, A., et al. (2017) · Nature · doi:10.1038/nature22969 · Cited by 611
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
Levin, A. M., Bates, D. L., Ring, A. M., Krieg, C., Lin, J. T., Su, L., Moraga, I., Raeber, M. E., Bowman, G. R., Novick, P., et al. (2012) · Nature · doi:10.1038/nature10975 · Cited by 552
Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology
23andMe Research Team, Ferreira, M. A., collaborators, A., BIOS consortium, Study, L. C., Vonk, J. M., Baurecht, H., Marenholz, I., Tian, C., Hoffman, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3985 · Cited by 550
Ballesteros-Tato, A., León, B., Graf, B. A., Moquin, A., Adams, P. S., Lund, F. E., & Randall, T. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.02.012 · Cited by 542
Growth Hormone Insensitivity Associated with a STAT5b Mutation
Kofoed, E. M., Hwa, V., Little, B., Woods, K. A., Buckway, C. K., Tsubaki, J., Pratt, K. L., Bezrodnik, L., Jasper, H., Tepper, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022926 · Cited by 525
Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells
Roediger, B., Kyle, R., Yip, K. H., Sumaria, N., Guy, T. V., Kim, B. S., Mitchell, A. J., Tay, S. S., Jain, R., Forbes-Blom, E., et al. (2013) · Nature Immunology · doi:10.1038/ni.2584 · Cited by 492
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γ c Receptors
Wang, X., Rickert, M., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1117893 · Cited by 475
Molofsky, A. B., Van Gool, F., Liang, H.-E., Van Dyken, S. J., Nussbaum, J. C., Lee, J., Bluestone, J. A., & Locksley, R. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.019 · Cited by 431
Self-citationCaudy, A. A., Reddy, S. T., Chatila, T., Atkinson, J. P., & Verbsky, J. W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.10.007 · Cited by 427
Lowe, C. E., Cooper, J. D., Brusko, T., Walker, N. M., Smyth, D. J., Bailey, R., Bourget, K., Plagnol, V., Field, S., Atkinson, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2102 · Cited by 424
Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus
Feng, Y., Arvey, A., Chinen, T., van der Veeken, J., Gasteiger, G., & Rudensky, A. Y. (2014) · Cell · doi:10.1016/j.cell.2014.07.031 · Cited by 422
Alcocer-Varela, J., & Alarcón-Segovia, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110579 · Cited by 420
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
Jin, Y., Birlea, S. A., Fain, P. R., Gowan, K., Riccardi, S. L., Holland, P. J., Mailloux, C. M., Sufit, A. J. D., Hutton, S. M., Amadi-Myers, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908547 · Cited by 415
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
Sharfe, N., Dadi, H. K., Shahar, M., & Roifman, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3168 · Cited by 409
Smigiel, K. S., Richards, E., Srivastava, S., Thomas, K. R., Dudda, J. C., Klonowski, K. D., & Campbell, D. J. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131142 · Cited by 405
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Sockolosky, J. T., Trotta, E., Parisi, G., Picton, L., Su, L. L., Le, A. C., Chhabra, A., Silveria, S. L., George, B. M., King, I. C., et al. (2018) · Science · doi:10.1126/science.aar3246 · Cited by 382
Self-citationThe UK-PSC Consortium, Ji, S.-G., The International IBD Genetics Consortium, The International PSC Study Group, Juran, B. D., Mucha, S., Folseraas, T., Jostins, L., Melum, E., Kumasaka, N., et al. (2017) · Nature Genetics · doi:10.1038/ng.3745 · Cited by 357
Nelson, B. H., Lord, J. D., & Greenberg, P. D. (1994) · Nature · doi:10.1038/369333a0 · Cited by 344
Genetic Variants Regulating Immune Cell Levels in Health and Disease
Orrù, V., Steri, M., Sole, G., Sidore, C., Virdis, F., Dei, M., Lai, S., Zoledziewska, M., Busonero, F., Mulas, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.041 · Cited by 337
McHugh, R. S., & Shevach, E. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5979 · Cited by 319
Immune homeostasis enforced by co-localized effector and regulatory T cells
Liu, Z., Gerner, M. Y., Van Panhuys, N., Levine, A. G., Rudensky, A. Y., & Germain, R. N. (2015) · Nature · doi:10.1038/nature16169 · Cited by 317
Betz, R. C., Petukhova, L., Ripke, S., Huang, H., Menelaou, A., Redler, S., Becker, T., Heilmann, S., Yamany, T., Duvic, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms6966 · Cited by 308
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Simeonov, D. R., Gowen, B. G., Boontanrart, M., Roth, T. L., Gagnon, J. D., Mumbach, M. R., Satpathy, A. T., Lee, Y., Bray, N. L., Chan, A. Y., et al. (2017) · Nature · doi:10.1038/nature23875 · Cited by 297
Self-citationKnoechel, B., Lohr, J., Kahn, E., Bluestone, J. A., & Abbas, A. K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050855 · Cited by 296
Self-citationCrystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor
Stauber, D. J., Debler, E. W., Horton, P. A., Smith, K. A., & Wilson, I. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511161103 · Cited by 288
Dendrou, C. A., Plagnol, V., Fung, E., Yang, J. H. M., Downes, K., Cooper, J. D., Nutland, S., Coleman, G., Himsworth, M., Hardy, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.434 · Cited by 274
Maier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., Clark, P. M., Healy, B., Walker, N., Aubin, C., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000322 · Cited by 245
Australian Asthma Genetics Consortium (AAGC), Bønnelykke, K., the EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium, Matheson, M. C., Pers, T. H., Granell, R., Strachan, D. P., Alves, A. C., Linneberg, A., Curtin, J. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2694 · Cited by 244
Cohen, A. C., Nadeau, K. C., Tu, W., Hwa, V., Dionis, K., Bezrodnik, L., Teper, A., Gaillard, M., Heinrich, J., Krensky, A. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2770 · Cited by 235
Cutting Edge: Mechanisms of IL-2–Dependent Maintenance of Functional Regulatory T Cells
Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W., Hofmann, J., O’Gorman, W. E., & Abbas, A. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903940 · Cited by 219
Self-citationSpangler, J. B., Tomala, J., Luca, V. C., Jude, K. M., Dong, S., Ring, A. M., Votavova, P., Pepper, M., Kovar, M., & Garcia, K. C. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.015 · Cited by 217
The Structure of Interleukin-2 Complexed with Its Alpha Receptor
Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1109745 · Cited by 212
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
Goudy, K., Aydin, D., Barzaghi, F., Gambineri, E., Vignoli, M., Mannurita, S. C., Doglioni, C., Ponzoni, M., Cicalese, M. P., Assanelli, A., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.004 · Cited by 211
Interleukin 2 deficiency is a common feature of autoimmune mice.
Dauphinée, M. J., Kipper, S., Wofsy, D., & Talal, N. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2483 · Cited by 199
A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
Trotta, E., Bessette, P. H., Silveria, S. L., Ely, L. K., Jude, K. M., Le, D. T., Holst, C. R., Coyle, A., Potempa, M., Lanier, L. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0070-2 · Cited by 199
Self-citationYu, A., Snowhite, I., Vendrame, F., Rosenzwajg, M., Klatzmann, D., Pugliese, A., & Malek, T. R. (2015) · Diabetes · doi:10.2337/db14-1322 · Cited by 197
Molecular regulation of interleukin‐2 expression by CD28 co‐stimulation and anergy
Powell, J. D., Ragheb, J. A., Kitagawa‐Sakakida, S., & Schwartz, R. H. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01246.x · Cited by 180
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
Mitra, S., Ring, A. M., Amarnath, S., Spangler, J. B., Li, P., Ju, W., Fischer, S., Oh, J., Spolski, R., Weiskopf, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.018 · Cited by 175
Bernasconi, A., Marino, R., Ribas, A., Rossi, J., Ciaccio, M., Oleastro, M., Ornani, A., Paz, R., Rivarola, M. A., Zelazko, M., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-2882 · Cited by 167
Charych, D. H., Khalili, S., Dixit, V., Kirk, P. B., Chang, T., Langowski, J. L., Rubas, W., Doberstein, S. K., Eldon, M. A., Hoch, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179431 · Cited by 155
The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells
O’Gorman, W. E., Dooms, H., Thorne, S. H., Kuswanto, W. F., Simonds, E. F., Krutzik, P. O., Nolan, G. P., & Abbas, A. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900691 · Cited by 152
Self-citationHwa, V., Little, B. M., Adıyaman, P., Kofoed, E. M., Pratt, K. L., Öçal, G., Berberoğlu, M., & Rosenfeld, R. G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0515 · Cited by 145
Krämer, S., Schimpl, A., & Hünig, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1769 · Cited by 142
Shanafelt, A. B., Lin, Y., Shanafelt, M.-C., Forte, C. P., Dubois‐Stringfellow, N., Carter, C., Gibbons, J. A., Cheng, S.-L., Delaria, K. A., Fleischer, R., et al. (2000) · Nature Biotechnology · doi:10.1038/81199 · Cited by 135
Gool, F. V., Molofsky, A. B., Morar, M. M., et al. (2014) · Blood · doi:10.1182/blood-2014-07-587493 · Cited by 120
Rad, R., Rad, L., Wang, W. T., Strong, A., Ponstingl, H., Bronner, I. F., Mayho, M., Steiger, K., Weber, J., Hieber, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3164 · Cited by 85
Gruenbacher, G., Gander, H., Nussbaumer, O., Nußbaumer, W., Rahm, A., & Thurnher, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1968 · Cited by 75
IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4 + and CD8 + T cells
Smith, G. A., TAUNTON, J. E., & Weiss, A. (2017) · Science Signaling · doi:10.1126/scisignal.aan4931 · Cited by 49
A cis -Acting Regulatory Variant in the IL2RA Locus
Qu, H., Verlaan, D. J., Ge, B., Lu, Y. Z., Lam, K. C. L., Grabs, R., Harmsen, E., Hudson, T. J., Hakonarson, H. H., Pastinen, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901337 · Cited by 21
Cited by
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
Togashi, Y., Shitara, K., & Nishikawa, H. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0175-7 · Cited by 1,546
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Toward personalized treatment approaches for non-small-cell lung cancer
Wang, M., Herbst, R. S., & Boshoff, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01450-2 · Cited by 1,093
Treg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Self-citationThe signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Metadata
- Authors
- Abbas, A. K., Trotta, E., R. Simeonov, D., Marson, A., & Bluestone, J. A.
- Venue
- Science Immunology
- Published
- 2018-07-20
- Volume
- 3
- Issue
- 25
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2830145191
- Cited by
- 636
- References
- 89
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.